Article Details

Latest FDA-Approved Preventive Treatment For Migraine, Qulipta, Enters A Highly ... - Forbes

Retrieved on: 2021-10-03 17:37:30

Tags for this article:

Click the tags to see associated articles and topics

Latest FDA-Approved Preventive Treatment For Migraine, Qulipta, Enters A Highly ... - Forbes. View article details on hiswai:

Excerpt

This includes four CGRP-targeting monoclonal antibodies – Aimovig (erenumab), ... For the monoclonal antibody CGRP antagonists, there is a mounting body of ...

Article found on: www.forbes.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up